Обзоры литературы
doi: 10.25005/2074-0581-2013-15-4-119-123
Биохимические маркёры в диагностике нарушений ремоделирования костной ткани при остеопорозе

И.С. Захаров, Г.И. Колпинский, Г.А. Ушакова, Г.В. Вавин

ГБОУ ВПО Кемеровская государственная медицинская академия, Российская Федерация

В обзоре представлены результаты научных исследований российских и зарубежных учёных, которые посвящены диагностике нарушений метаболизма костной ткани, возникающих при остеопорозе. Исследователи выделяют две группы маркёров костного обмена: маркёры костеобразования и маркёры резорбции кости. В приведённой статье даются ссылки на использование указанных биохимических показателей как в диагностике остеопороза, так и в оценке эффективности антирезорбтивной терапии.

Ключевые слова: остеопороз, маркёры костеобразования, маркёры резорбции кости, ремоделирование костной ткани.

Скачать файл:

Литература
  1. Frost H.M. Dynamics of bone remodeling // In: H.M.Frost (ed.). Bone Biodinamics. Boston, 1964; p. 315-333.
  2. Avioli L.V. Senil and postmenopausal osteoporosis. // Adv. Internat. Med. 1976; 21:391-415.
  3. Consensus Development Conference. Diagnosis, prophylaxis, and treatment of osteoporosis / L.V.Avioli // American Journal of Medicine. – 1993; 94:646-650.
  4. Лесняк О.М. Аудит состояния проблемы остеопороза в Российской Федерации / О.М.Лесняк // Профилактическая медицина. - 2011. - №2. - С.7- 10.
  5. Schuit S.C. Fracture incidence and association with bone mineral density in elderly men and women / S.C.Schuit [et al.] // The Rotterdam Study. Bone 34, 195–202 (2004).
  6. Sornay-Rendu E. Identification of osteopenic women at high risk of fracture: The OFELY study / E.Sornay-Rendu [et al.] // J Bone Miner Res 20, 1813–1819 (2005).
  7. Клинические рекомендации. Остеопороз // Под редакцией О.М.Лесняк, Л.И.Беневоленской. – 2-е изд., перераб. и доп. – М.: ГЭОТАР-Медиа. - 2009. – 272 с.
  8. Brown J.P. Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis / J.P.Brown [et al.] // Lancet. 1984;1:1091–1093.
  9. Garnero P. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study / P.Garnero [et al.] // J. Bone Miner Res. 1996;11:1531–1538.
  10. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study / P.Garnero, E.Sornay-Rendu, B.Claustrat, P.D.Delmas // J. Bone Miner Res. 2000; 15:1526–1536.
  11. Современные методы диагностики, профилактики и лечения остеопороза / Л.Б.Дрыгина, И.В.Трофимова, О.А.Саблин, И.Д.Никифорова. – Методическое пособие. – СПб: ВЦЭРМ им. А.М. Никифорова МЧС России. - 2011. – 86 с.
  12. Bouillon R. Homologous radioimmunoassay of human osteocalcin / R.Bouillon [et al.] // Clin Chem 1992;38:2055–2060.
  13. Delmas P.D. Increase in serum bone gammacarboxyglutamic acid protein with aging in women / P.D.Delmas [et al.] // J. Clin lnvest 1983;71:1316– 1321.
  14. Gundberg C.M. Determination of osteocalcin in human serum: results with two kits compared with those by a well-characterized assay / C.M.Gundberg [et al.] // Clin Chem. 1985;31:1720–1723.
  15. Taylor A.K. Development of a new radioimmunoassay for human osteocalcin: evidence for a midmolecule epitope / A.K.Taylor [et al.] // Metabolism. - 1988;37:872–877.
  16. Diego E.D. Six osteocalcin assays compared / E.D.Diego // Clin Chem. - 1994;40:2071–2077.
  17. Liu S.H. Collagen in tendon, ligament, and bone healing. A current review / S.H.Liu // Clin Orthop. - 1995;318:265–278.
  18. Masters P.W. Commercial assays for serum osteocalcin give clinically discordant result / P.W.Masters // Clin Chem 1994;40:358–363.
  19. Dumon J.C. Technical and clinical validation of a new immunoradiometric assay for human osteocalcin / J.C.Dumon, H.Wantier, J.J.Mathieu, J.J.Body // Eur.. J. Endocrinol. - 1996;135:231–237.
  20. Endres D.B. Biochemical markers of bone metabolism / D.B.Endres // J. Clin. Ligand Assay. - 1998. - Vol. 21, N 2. - P. 89-256.
  21. Koyama I. Sugar-chain heterogeneity of human alkaline phosphatases: differences between normal and tumor-associated isoenzymes / I.Koyama, M.Miura, H.Matsuzaki, Y.Sakagishi // Am. J. Dis. Child. - 1985;139:736–740.
  22. Green S. Automated differential isoenzyme analysis. II. The fractionation of serum alkaline phosphatase into liver, intestinal, and other components / S.Green, C.L.Antiss, W.H.Fishman //. - 1971;41:9–26.
  23. Van Hoof V.O. Age and sex distribution of alkaline phosphatase isoenzymes by agarose electrophoresis / V.O.Van Hoof [et al.] // Clin Chem 1990; 36:875–878.
  24. Garnero P. Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women / P.Garnero, P.D.Delmas // J. Musculoskelet Neuronal Interact. – 2004. – № 4(1). – P. 50–63.
  25. Farley J.R. Improved method for quantitative determination in serum of alkaline phosphatase of skeletal origin / J.R.Farley, C.H.Chesnut, D.J.Baylink // Clin Chem 1981;27:2002–2007.
  26. Gorman L. Clinical usefulness of alkaline phosphatase isoenzyme determinations / L.Gorman, B.E.Statland // Clin. Biochem. - 1977;10:171–174.
  27. Martin M. Analytical and clinical evaluation of a method to quantify bone alkaline phosphatase, a marker of osteoblastic activity / M.Martin [et al.] // Anticancer Res 1997;17: 3167–3170.
  28. Garnero P. Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis / P.Garnero, P.Vergnaud, N.Hoyle // Clin. Chem. – 2008. – № 54(1). – P. 188–196.
  29. Bonnick S.L. Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both? / S.L.Bonnick, L.Shulman // Am. J. Med. – 2006 Apr. – № 119 (4 Suppl 1). – S25–31.
  30. Lowry M. Hydroxyproline metabolism by the rat kidney: distribution of renal enzymes of hydroxyproline catabolism and renal conversion of hydroxyproline to glycine and serine / M.Lowry, D.Hall, J.Brosnan // Metabolism. - 1985;34:955–961.
  31. Robins S.P. Turnover of collagen and its precursors / S.P.Robins // Biology of collagen. Academic Press: New York. - 1980:135–151.
  32. The biosynthesis of collagen and its disorders / D.J.Prockop, K.I.Kivirikko, L.Tuderman, N.A.Guzman // New Engl J Med 1979;301:13–23.
  33. Kivirikko K.I. Urinary excretion of hydroxyproline in health and disease / K.I.Kivirikko // Int Rev Connect Tissue Res 1970;5:93–163.
  34. Krane S.M. Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation / S.M.Krane [et al.] // J. Clin. Invest. - 1977;59:819–827.
  35. Majima T. Efficacy of combined treatment with raloxifene and alfacalcidol on bone density and biochemical markers of bone turnover in postmenopausal osteoporosis / T.Majima [et al.] // Endocr. J. – 2008. – № 55(1). – P. 127–134.
  36. Black D.M. Horizon Pivotal Fracture Trial. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis / D.M.Black [et al.] // N. Engl. J. Med. – 2007. – №356 (18). – P. 1809–1822.
  37. McClung M. Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate / M.McClung [et al.] // Bone. – 2007. – № 41(1). – P. 122–128
  38. Meunier P.J. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis / P.J.Meunier [et al.] // N. Engl. J. Med. – 2004. – № 350(5). – P. 459–468.
  39. Saag K. A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density / K.Saag [et al.] // Bone. – 2007 May. – № 40(5). – P. 1238–1243.
  40. Markus J. Seibel The use of molecular markers of bone turnover in the management of patients with metastatic bone disease / J.Markus // Clinical Endocrinology. - 2008. - V.68. - P.839–849.
  41. Kuchuk N.O. The association of sex hormone levels with quantitative ultrasound, bone mineral density, bone turnover and osteoporotic fractures in older men and women / N.O.Kuchuk [et al.] // Clin. Endocrinol (Oxf ). – 2007. – № 67(2). – P. 295–303.

Адрес для корреспонденции:

Захаров Игорь Сергеевич
доцент кафедры акушерства и гинекологии №1 Кемеровской государственной медицинской академии

Российская Федерация, г.Кемерово, ул. Ворошилова, 22а

E-mail: isza@mail.ru

◄ Возврат к списку